Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studying Some Epigenetic Modifications In Glioblastoma Multiforme and Their Impact On Clinical Outcome

NCT06538428 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06538428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06538428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studying Some Epigenetic Modifications In Glioblastoma Multiforme and Their Impact On Clinical Outcome
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
September 1, 2020
Completion date
December 9, 2022
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gbm